Cardiology

Fewer deaths with self-expanding TAVR versus surgery at one year

Transcatheter aortic valve replacement with a self-expanding valve prosthesis for the first time has demonstrated significantly lower death rates at one year compared with conventional surgical valve replacement in high-risk ...

Cardiology

New heart valve shows high survival rates in study

Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery.

Cardiology

Results of the REPRISE II trial reported

In a clinical trial, a second-generation transcatheter aortic valve demonstrated low rates of complications that are sometimes seen in transcatheter aortic valve replacement (TAVR), including challenges with positioning, ...

Cardiology

Results of the COREVALVE EXTREME RISK trial presented

In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for surgery.Results of the COREVALVE ...

Cardiology

TAVI feasible in bicuspid aortic valve

Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve, according to research presented at ESC Congress 2013 today by Dr. Timm Bauer from Germany. The findings open up a new treatment ...

Cardiology

Women less likely to die after TAVI than men

Women are 25 percent less likely to die one year after TAVI than men, according to research presented at the ESC Congress today by Dr. Mohammad Sherif from Germany. The findings suggest that TAVI might be the preferred treatment ...

page 12 from 14